诊疗知识库_医脉通

浆细胞白血病 - 参考文献

概览: 简介; 名称与编码; 精要; 历史; 致谢; 缩略语表

基础: 定义; 流行病学; 病因; 病理解剖; 病理生理; 分类分型

预防: 预防; 筛检

诊断: 问诊与查体; 疾病演变; 辅助检查; 并发症; 诊断标准; 诊断程序; 鉴别诊断

治疗: 治疗目标; 治疗细则; 管理与监测; 治疗程序; 治疗进展; 护理与照顾

随访: 随访要点; 预后; 患者教育

临床资料: 诊疗指南; 临床路径; 病例; 临床问题

文献资料: 参考文献; 网络资源; 推荐文献; 课件; 图片

聚合阅读>>

参考文献

简介

[1]	王杨，杨梓梅，李秀杰。浆细胞白血病10例报告。白血病，2000，9（2）：107-108

[2]	杨仁池，钱林生，卞寿庚。原发性浆细胞白血病（附11例报告）。白血病，1999，8（6）：333-334

Vela-Ojeda J,García-Ruiz Esparza MA,Rosas-Cabral A,Padilla-González Y,García-Chávez J,Tripp-Villanueva F,Sánchez-Cortés E,Ayala-Sánchez M,García-León LD,Montiel-Cervantes L,Rubio-Borja ME. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia. Ann Hematol. 2002 Jul. 81(7): 362-7.

pubmed摘要

[2]	庄俊玲，武永吉，钟玉萍，等。多发性骨髓瘤218例临床资料分析。中国实用内科杂志，2003，,42:38

病理生理

[1]	Pellat-Deceunynck C,Barillé S,Jego G,Puthier D,Robillard N,Pineau D,Rapp MJ,Harousseau JL,Amiot M,Bataille R. The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma. Leukemia. 1998 Dec. 12(12): 1977-82.
	pubmed摘要

[2]	García-Sanz R,Orfão A,González M,Tabernero MD,Bladé J,Moro MJ,Fernández-Calvo J,Sanz MA,Pérez-Simón JA,Rasillo A,Miguel JF. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood. 1999 Feb 1. 93(3): 1032-7.
	pubmed摘要 \| 全文链接

[3]	Barker HF,Hamilton MS,Ball J,Drew M,Franklin IM. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. Br J Haematol. 1992 Jul. 81(3): 331-5.
	pubmed摘要

[4]	Van Riet I,De Waele M,Remels L,Lacor P,Schots R,Van Camp B. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells. Br J Haematol. 1991 Nov. 79(3): 421-7.
	pubmed摘要

[5]	Avet-Loiseau H,Andree-Ashley LE,Moore D 2nd,Mellerin MP,Feusner J,Bataille R,Pallavicini MG. Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes Chromosomes Cancer. 1997 Jun. 19(2): 124-33.
	pubmed摘要

[6]	Gutiérrez NC,Hernández JM,García JL,Cañizo MC,González M,Hernández J,González MB,Garciá-Marcos MA,San Miguel JF. Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization. Leukemia. 2001 May. 15(5): 840-5.
	pubmed摘要

[7]	Shimazaki C,Goto H,Araki S,Tatsumi T,Takahashi R,Hirai H,Kikuta T,Yamagata N,Ashihara E,Inaba T,Fujita N,Suzuki R,Nakagawa M. Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11;14)(q13;q32). Int J Hematol. 1997 Jul. 66(1): 111-5.
	pubmed摘要

诊断标准

[1]	张之南，沈悌主编。《血液病诊断及疗效标准》第三版，科学出版社，1991年1月第1版，126-127.

[2]	Kyle RA,Maldonado JE,Bayrd ED. Plasma cell leukemia. Report on 17 cases. Arch Intern Med. 1974 May. 133(5): 813-8.
	pubmed摘要

[3]	Jaffe ES,Harris NL,Diebold J,Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol. 1999 Jan. 111(1 Suppl 1): S8-12.
	pubmed摘要

治疗细则

[1]	Dimopoulos MA,Palumbo A,Delasalle KB,Alexanian R. Primary plasma cell leukaemia. Br J Haematol. 1994 Dec. 88(4): 754-9.
	pubmed摘要

[2]	2. 陈少华，赵已昕，杨丽红。改良VCMP方案治疗浆细胞白血病9例。陕西医学杂志，2002，31（8）：720-721

[3]

pubmed摘要

[4]	4. 杨仁池，钱林生，卞寿庚。原发性浆细胞白血病（附11例报告）。白血病，1999，8（6）：333-334

[5]	5. 王杨，杨梓梅，李秀杰。浆细胞白血病10例报告。白血病，2000，9（2）：107-108

[6]	Johnston RE,Abdalla SH. Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia. Leuk Lymphoma. 2002 Feb. 43(2): 351-4.
	pubmed摘要

[7]	Gemmel C,Cremer FW,Weis M,Witzens M,Moldenhauer G,Koniczek KH,Imbach U,Ho AD,Moos M,Goldschmidt H. Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation. Ann Hematol. 2002 Feb. 81(2): 119-23.
	pubmed摘要

[8]	Hovenga S,de Wolf JT,Klip H,Vellenga E. Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature. Bone Marrow Transplant. 1997 Nov. 20(10): 901-4.
	pubmed摘要 \| 全文链接

[9]	Sica S,Chiusolo P,Salutari P,Piccirillo N,Laurenti L,Ortu La Barbera E,Serra FG,Leone G. Long-lasting complete remission in plasma cell leukemia after aggressive chemotherapy and CD34-selected autologous peripheral blood progenitor cell transplant: molecular follow-up of minimal residual disease. Bone Marrow Transplant. 1998 Oct. 22(8): 823-5.
	pubmed摘要 \| 全文链接

[10]	Mak YK,Chan CH,Chen YT,Lau SM,So CC,Wong KF. Consolidation therapy with autologous blood stem cell transplantation in a patient with primary plasma cell leukaemia. Clin Lab Haematol. 2003 Feb. 25(1): 55-8.
	pubmed摘要

[11]	Mele G,Pinna S,Melpignano A,Quarta G. Retrospective case series of three patients with plasma cell leukemia treated with bortezomib-based regimens. Clin Ther. 2010 May. 32(5): 915-9.
	pubmed摘要

[12]	Guglielmelli T,Merlini R,Giugliano E,Saglio G. Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia. J Oncol. 2009. 2009(): 867380.
	pubmed摘要 \| 全文链接

治疗进展

[1]	Katodritou E,Verrou E,Gastari V,Hadjiaggelidou C,Terpos E,Zervas K. Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome? Leuk Res. 2008 Jul. 32(7): 1153-6.
	pubmed摘要